OKLAHOMA CITY — Oklahoma has enacted a new law making the distribution of abortion-inducing drugs a felony, deepening the state’s already strict abortion ban and opening a new front in the legal and political fight over medication abortion.
Gov. Kevin Stitt signed House Bill 1168 into law May 5, according to the Oklahoma House of Representatives, with a ceremonial signing held later alongside supporters of the measure.
Authored by Rep. Denise Crosswhite Hader, R-Piedmont, and Sen. David Bullard, R-Durant, the law creates a felony offense for knowingly possessing or delivering abortion-inducing drugs — including mifepristone and misoprostol — to someone intending to use them for an unlawful abortion.
Violations carry penalties of up to 10 years in prison, a $100,000 fine, or both, aligning with existing criminal penalties for performing an illegal abortion under Oklahoma law.
Oklahoma already bans most abortions except in medical emergencies to save the life of the mother, a policy framework reshaped after the U.S. Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision overturned federal abortion protections. Since then, Republican lawmakers have steadily moved to tighten enforcement mechanisms around the ban.
Supporters of HB 1168 say the measure targets what they describe as an emerging pipeline of abortion pills entering the state outside traditional medical channels. Crosswhite Hader said the legislation is aimed at preventing non-medical distribution of the drugs, which she argued can pose serious risks if used without proper supervision.
Bullard, the Senate sponsor, used stark and controversial comparisons in support of the bill, casting the distribution of abortion medication in sweeping moral terms as lawmakers advanced the measure.
The law does not criminalize individuals who obtain abortion pills for their own use, focusing instead on those who distribute or attempt to distribute the drugs unlawfully. It also includes carve-outs for licensed pharmacists, manufacturers and distributors operating within legal medical guidelines.
Additionally, the measure specifies that medications prescribed for other medical purposes — including cancer treatments, treatment of ectopic pregnancies or miscarriage care — are not subject to the new restrictions.
Legal questions surrounding abortion pills remain unsettled nationwide, particularly regarding federal authority over drug approval and interstate distribution, setting up the potential for court challenges as states like Oklahoma move to restrict access.
Abortion-rights advocates have broadly argued that such laws could limit access to care and raise enforcement concerns, though no immediate legal challenge to HB 1168 had been filed as of its signing.
The bill passed the House in 2025 and cleared the Senate this year before reaching the governor’s desk.
With the law now in effect, Oklahoma is continuing to shift the abortion battleground beyond clinics and into the distribution of medication — a move likely to test the limits of state authority in a post-Dobbs landscape.
